ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

WVE Wave Life Sciences Ltd

5.01
0.17 (3.51%)
Last Updated: 13:14:29
Delayed by 15 minutes

Period:

Draw Mode:

Volume 155,327
Bid Price 5.00
Ask Price 5.02
News (1)
Day High 5.1651

Low
2.50

52 Week Range

High
7.67

Day Low 4.95
Company Name Stock Ticker Symbol Market Type
Wave Life Sciences Ltd WVE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.17 3.51% 5.01 13:14:29
Open Price Low Price High Price Close Price Prev Close
5.13 4.95 5.1651 4.84
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,066 155,327 $ 5.07 $ 787,990 - 2.50 - 7.67
Last Trade Time Type Quantity Stock Price Currency
13:23:38 44 $ 5.01 USD

Wave Life Sciences Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
612.64M 122.28M - 3.66M -161.82M -1.32 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Wave Life Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No WVE Message Board. Create One! See More Posts on WVE Message Board See More Message Board Posts

Historical WVE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.685.794.644.91527,336-0.67-11.80%
1 Month5.856.324.645.69535,089-0.84-14.36%
3 Months4.457.673.505.49928,2360.5612.58%
6 Months5.527.673.505.25776,920-0.51-9.24%
1 Year4.307.672.504.97573,5560.7116.51%
3 Years6.127.671.164.60514,943-1.11-18.14%
5 Years25.8239.991.167.77565,333-20.81-80.60%

Wave Life Sciences Description

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.

Your Recent History

Delayed Upgrade Clock